Claudio M.
- Country
- Italy
- Department
- UOC Pediatria B Ospedale della Donna e del bambino
Research Overview
- Efficacy and Safety of Cagrilintide Monotherapy and Cagrilintide plus Semaglutide for Weight Management in Children and Adolescents with Overweight or Obesity
- A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy
- Randomized, Double-Blind, Multicenter Study Evaluating Inclisiran Versus Placebo in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
Data & Insights
Has run more than one trial at 52 of 178 partner sites.
Specializations
Metabolic Disorders
This investigator demonstrates significant expertise in treating Type 1 diabetes mellitus, focusing particularly on innovative approaches to preserve endogenous insulin secretion in adolescents and young adults with newly diagnosed conditions.
- Early-stage diabetes management
- Insulin preservation therapy
- Adolescent diabetes care
The research extends to evaluating novel therapeutic agents for maintaining natural insulin production.
Weight Management
The investigator specializes in treating obesity and overweight conditions in pediatric and adolescent populations, with particular attention to weight reduction strategies and long-term maintenance approaches.
- Adolescent weight management
- BMI reduction therapies
- Weight maintenance protocols
Their work encompasses both immediate weight reduction and sustained weight management strategies.
Lipid Disorders
The investigator focuses on treating heterozygous familial hypercholesterolemia in pediatric patients, particularly addressing elevated LDL-C levels in children between 6 and 12 years of age.
- Pediatric cholesterol management
- Genetic lipid disorders
- Early intervention strategies
Their expertise extends to innovative therapeutic approaches for managing inherited lipid disorders in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.